Cautionary tales of survival analysis: conflicting analyses from a clinical trial in breast cancer
Open Access
- 1 August 1997
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 76 (4), 551-558
- https://doi.org/10.1038/bjc.1997.424
Abstract
Data from a completed randomized trial in breast cancer are used to demonstrate and quantify the variation in estimated survival curves and log-rank statistics at different times throughout a trial. False 'plateaux' are common, as are wide fluctuations in chi2 values obtained from the log-rank test when there are few events. We show how analyses conducted at different times can demonstrate different effects. Long follow-up is often necessary to allow correct interpretation of results. We discuss the assumption of proportional hazards and the consequences of making that assumption inappropriately. We show how checking whether hazards are proportional can help in avoiding erroneous conclusions.Keywords
This publication has 9 references indexed in Scilit:
- On the development of the medical research council trial of α-interferon in metastatic renal carcinomaStatistics in Medicine, 1994
- The clinical importance of early stopping of randomized trials in cancer treatmentsStatistics in Medicine, 1994
- A reversal of fortune: Practical problems in the monitoring and interpretation of an EORTC breast cancer trialStatistics in Medicine, 1994
- Interim analyses and stopping rules in cancer clinical trialsBritish Journal of Cancer, 1993
- Interim analyses for monitoring clinical trials that do not materially affect the type I error rateStatistics in Medicine, 1992
- Weighted Kaplan-Meier Statistics: A Class of Distance Tests for Censored Survival DataBiometrics, 1989
- Locally advanced breast cancer: The contribution of cytotoxic and endocrine treatment to radiotherapyEuropean Journal of Cancer and Clinical Oncology, 1989
- Tables of the number of patients required in clinical trials using the logrank testStatistics in Medicine, 1982
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977